Brenda Maloney Shafer Shares Perspective in Modern Healthcare Article About Proposed 340B Reimbursement Plan
Brenda Maloney Shafer, national vice chair of the Quarles & Brady Health & Life Sciences Practice Group, offered insight for a Modern Healthcare article about a recent proposal by the Centers for Medicare and Medicaid Services (CMS) regarding reimbursements to hospitals participating in the 340B drug discount program.
The proposal addresses how 340B hospitals that treat low income and uninsured hospitals would be reimbursed for costs incurred. Shafer commented on how the payment process would work, if the proposal goes through. An excerpt:
Hospitals are reviewing the remedy payment amounts to ensure that they match their calculations regarding the 340B payment adjustments.
The amount of remedy payment each hospital will receive under the proposed rule varies widely. The University of Kansas Hospital in Kansas City, for instance, would receive more than $100 million, while nearly 900 hospitals would receive less than $1 million, according to an addendum to the proposed rule issued by CMS.
If finalized, the payments would be distributed through Medicare contractors. The chances of misallocation are relatively low, said Brenda Maloney Shafer, a partner at law firm Quarles & Brady